Time and place:
January 2026, 8:30–9:15 am Online or meeting room Tarlebø, Alrek health cluster Language: Norwegian Coffee and tea will be served
Pandemic Breakfast: What does the new infection control law mean for law and public health?
UiB project receives over five million euros to reduce child mortality
UiB has received 5.3 million euros from the EU for the PRoRota project, which will investigate whether probiotics, better hygiene education and mathematical models can reduce child mortality related to diarrhea in low- and middle-income countries. The project tests whether probiotics can improve the effect of the rotavirus vaccine in a large study with 4,000 newborns in Tanzania, Malawi and Ivory Coast. In addition, a warning system for rotavirus outbreaks is being developed and research is being conducted on how WASH routines can work better in practice.
Announcement of the Neuro-SysMed seminar on 4 February
Wednesday 4 February – 11:30-13:00 – Auditorium in Armauer Hansens HusTranslating biomedical discoveries into scalable medical solutions is still slow, with many innovations stalling in the “translation gap”. Misaligned incentives, professional silos and weak links between academia, healthcare…
CCBIO Seminar January 29, 2026: Katrin Kleinmanns presents award-winning research
CCBIO welcomes you to the first spring seminar of 2026, which will take place on Thursday, January 29th in auditorium 4 at BBB. The event is open to all, and no registration is required. This time, CCBIO researcher Katrin Kleinmanns will be on stage, presenting the work that earned her the Young Cancer Researcher Award.
Welcome to CancerREHAB 2026 in Tromsø!
On April 13–14, 2026, professional communities from all over the country will gather at Scandic Ishavshotell when the national professional conference KreftREHAB is held in Tromsø for the first time. The conference is the year's most important meeting place for everyone working with cancer rehabilitation, and offers two days of professional in-depth study, inspiration and networking.